These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2624171)

  • 1. Metabolic activation of 2,6-diaminopurine and 2,6-diaminopurine-2'-deoxyriboside to antitumor agents.
    Weckbecker G; Cory JG
    Adv Enzyme Regul; 1989; 28():125-44. PubMed ID: 2624171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2,6-Diaminopurinedeoxyriboside as a prodrug of deoxyguanosine in L1210 cells.
    Weckbecker G; Cory JG
    Cancer Res; 1987 May; 47(9):2218-23. PubMed ID: 3552212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2'-Deoxy-2'-methylene derivatives of adenosine, guanosine, tubercidin, cytidine and uridine as inhibitors of L1210 cell growth in culture.
    Cory AH; Samano V; Robins MJ; Cory JG
    Biochem Pharmacol; 1994 Jan; 47(2):365-71. PubMed ID: 8304981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparative effects of 5'-methylthioadenosine and some of its analogs on cells containing, and deficient in, 5'-methylthioadenosine phosphorylase.
    White MW; Riscoe MK; Ferro AJ
    Biochim Biophys Acta; 1983 Jun; 762(3):405-13. PubMed ID: 6405800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antineoplastic effect of the combination of 2,3-dihydro-1H-pyrazole[2,3a]imidazole plus deoxyadenosine/erythro-9-(2-hydroxyl-3-nonyl)adenine in mice with L1210 leukemia cells.
    Matsumoto M; Weckbecker G; Cory JG
    Cancer Commun; 1990; 2(1):1-6. PubMed ID: 2369548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N6-cyclopropyl-PMEDAP: a novel derivative of 9-(2-phosphonylmethoxyethyl)-2,6-diaminopurine (PMEDAP) with distinct metabolic, antiproliferative, and differentiation-inducing properties.
    Hatse S; Naesens L; De Clercq E; Balzarini J
    Biochem Pharmacol; 1999 Jul; 58(2):311-23. PubMed ID: 10423173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytological studies on the antimetabolite action of 2, 6-diaminopurine in Vicia faba roots.
    SETTERFIELD G; DUNCAN RE
    J Biophys Biochem Cytol; 1955 Sep; 1(5):399-419. PubMed ID: 13263329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection and characterisation of murine leukaemia L1210 cells with high-level resistance to the cytostatic activity of the acyclic nucleoside phosphonate 9-(2-phosphonylmethoxyethyl) adenine (PMEA).
    Balzarini J; Hatse S; Naesens L; De Clercq E
    Biochim Biophys Acta; 1998 Mar; 1402(1):29-38. PubMed ID: 9551083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nucleoside transport inhibitors on the salvage and toxicity of adenosine and deoxyadenosine in L1210 and P388 mouse leukemia cells.
    Plagemann PG; Wohlhueter RM
    Cancer Res; 1985 Dec; 45(12 Pt 1):6418-24. PubMed ID: 3877568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5'-Deoxy-5'-methylthioadenosine phosphorylase--III. Role of the enzyme in the metabolism and action of 5'-halogenated adenosine analogs.
    Savarese TM; Chu SH; Chu MY; Parks RE
    Biochem Pharmacol; 1985 Feb; 34(3):361-7. PubMed ID: 3918539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5'-deoxy-5'-methylthioadenosine phosphorylase--II. Role of the enzyme in the metabolism and antineoplastic action of adenine-substituted analogs of 5'-deoxy-5'-methylthioadenosine.
    Savarese TM; Dexter DL; Parks RE
    Biochem Pharmacol; 1983 Jun; 32(12):1907-16. PubMed ID: 6411095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different relationships between cellular adenosine or 3'-deoxyadenosine phosphorylation and cellular adenine ribonucleotide catabolism may be obtained.
    Overgaard-Hansen K; Klenow H
    J Cell Physiol; 1993 Jan; 154(1):71-9. PubMed ID: 8419409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of nucleoside kinase-deficient mouse leukemia L1210 cell lines to determine metabolic routes of activation of antitumor nucleoside analogs.
    Cory AH; Cory JG
    Adv Enzyme Regul; 1994; 34():1-12. PubMed ID: 7942266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of N-hydroxy-N'-aminoguanidine isoquinoline in combination with other inhibitors of ribonucleotide reductase on L1210 cells.
    Weckbecker G; Weckbecker A; Lien EJ; Cory JG
    J Natl Cancer Inst; 1988 Jun; 80(7):491-6. PubMed ID: 2452889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase.
    Carson DA; Wasson DB; Lakow E; Kamatani N
    Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3848-52. PubMed ID: 6808516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproliferative effects of 4',5'-unsaturated adenine nucleosides on leukemia L1210 cells in vitro.
    Sheid B; Lerner LM; Gaetjens E
    Experientia; 1989 Aug; 45(8):729-30. PubMed ID: 2759202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purinogenic immunodeficiency diseases. Differential effects of deoxyadenosine and deoxyguanosine on DNA synthesis in human T lymphoblasts.
    Wilson JM; Mitchell BS; Daddona PE; Kelley WN
    J Clin Invest; 1979 Nov; 64(5):1475-84. PubMed ID: 115901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purine modulation of thymidine activity in L1210 leukemia cells in vitro.
    Leyva A; Appel H; Pinedo HM
    Leuk Res; 1982; 6(4):483-90. PubMed ID: 7144228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemia L1210 cell lines resistant to ribonucleotide reductase inhibitors.
    Cory JG; Carter GL
    Cancer Res; 1988 Feb; 48(4):839-43. PubMed ID: 3276399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deoxyadenosine triphosphate as a mediator of deoxyguanosine toxicity in cultured T lymphoblasts.
    Mann GJ; Fox RM
    J Clin Invest; 1986 Nov; 78(5):1261-9. PubMed ID: 3490493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.